Goldcoast Resource Corp. (GCR.CX)
0.45
-0.15
(-25.00%)
CAD |
CNSX |
Oct 13, 16:00
Goldcoast Resource Enterprise Value : 0.6993M for Oct. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 13, 2026 | 0.6993M |
| October 09, 2026 | 1.047M |
| October 08, 2026 | 1.140M |
| October 07, 2026 | 1.279M |
| October 06, 2026 | 1.233M |
| October 05, 2026 | 1.256M |
| October 02, 2026 | 1.325M |
| October 01, 2026 | 1.511M |
| September 30, 2026 | 1.627M |
| September 29, 2026 | 1.627M |
| September 28, 2026 | 1.627M |
| September 25, 2026 | 1.372M |
| September 24, 2026 | 1.395M |
| September 23, 2026 | 1.395M |
| September 22, 2026 | 1.488M |
| September 21, 2026 | 1.511M |
| September 18, 2026 | 1.580M |
| September 17, 2026 | 1.580M |
| September 16, 2026 | 1.488M |
| September 15, 2026 | 1.511M |
| September 14, 2026 | 1.557M |
| September 11, 2026 | 1.604M |
| September 10, 2026 | 1.580M |
| September 09, 2026 | 1.534M |
| September 08, 2026 | 1.580M |
| Date | Value |
|---|---|
| September 04, 2026 | 1.580M |
| September 03, 2026 | 1.511M |
| September 02, 2026 | 1.627M |
| September 01, 2026 | 1.974M |
| August 31, 2026 | 1.627M |
| August 28, 2026 | 1.627M |
| August 27, 2026 | 1.395M |
| August 26, 2026 | 1.511M |
| August 25, 2026 | 1.557M |
| August 24, 2026 | 1.511M |
| August 21, 2026 | 1.534M |
| August 20, 2026 | 1.418M |
| August 19, 2026 | 1.534M |
| August 18, 2026 | 1.604M |
| August 17, 2026 | 1.627M |
| August 14, 2026 | 1.627M |
| August 13, 2026 | 1.627M |
| August 12, 2026 | 1.743M |
| August 11, 2026 | 1.743M |
| August 10, 2026 | 1.789M |
| August 07, 2026 | -0.2634M |
| August 06, 2026 | -0.2634M |
| August 05, 2026 | -0.2634M |
| August 04, 2026 | -0.2634M |
| July 31, 2026 | -0.2634M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Kane Biotech, Inc. | 6.235M |
| Quest PharmaTech, Inc. | 4.368M |
| BriaCell Therapeutics Corp. | 6.578M |
| Vaxil Bio Ltd. | 0.1137M |
| Waverley Pharma, Inc. | 4.099M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0999M |
| Total Expenses (Quarterly) | 0.0999M |
| EPS Diluted (Quarterly) | -0.0431 |
| Earnings Yield | -39.36% |
| Normalized Earnings Yield | -38.49 |